
### [MONDO:0018904](http://purl.obolibrary.org/obo/MONDO_0018904)
**Label:** primary membranoproliferative glomerulonephritis

**Subclasses:** [MONDO:0012350](http://purl.obolibrary.org/obo/MONDO_0012350) (complement factor H deficiency), [MONDO:0014005](http://purl.obolibrary.org/obo/MONDO_0014005) (immunoglobulin-mediated membranoproliferative glomerulonephritis), [MONDO:0018013](http://purl.obolibrary.org/obo/MONDO_0018013) (non-immunoglobulin-mediated membranoproliferative glomerulonephritis), 

**Corr. equiv. classes:** [OMIM:609814](http://purl.obolibrary.org/obo/OMIM_609814), [Orphanet:329918](http://www.orpha.net/ORDO/Orphanet_329918), [OMIM:615008](http://purl.obolibrary.org/obo/OMIM_615008), [Orphanet:329903](http://www.orpha.net/ORDO/Orphanet_329903), 

**Class expressions from DL-Learner:**

- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0031263](http://purl.obolibrary.org/obo/HP_0031263) (Abnormal renal corpuscle morphology) 62.50%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 62.50%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 62.50%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0012210](http://purl.obolibrary.org/obo/HP_0012210) (Abnormal renal morphology) 62.50%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and [HP:0011035](http://purl.obolibrary.org/obo/HP_0011035) (Abnormality of renal cortex morphology) 62.50%
- [HP:0004722](http://purl.obolibrary.org/obo/HP_0004722) (Thickening of the glomerular basement membrane) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0003774](http://purl.obolibrary.org/obo/HP_0003774) (Stage 5 chronic kidney disease) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0003676](http://purl.obolibrary.org/obo/HP_0003676) (Progressive) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0003110](http://purl.obolibrary.org/obo/HP_0003110) (Abnormality of urine homeostasis) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0000100](http://purl.obolibrary.org/obo/HP_0000100) (Nephrotic syndrome) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0000095](http://purl.obolibrary.org/obo/HP_0000095) (Abnormality of renal glomerulus morphology) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0000093](http://purl.obolibrary.org/obo/HP_0000093) (Proteinuria) and [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) 62.50%
- [HP:0005575](http://purl.obolibrary.org/obo/HP_0005575) (Hemolytic-uremic syndrome) and (not ([HP:0100519](http://purl.obolibrary.org/obo/HP_0100519) (Anuria))) 62.50%


